TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Like the PNPLA3 variant, TM6SF2 rs58542926 contributes to the progressive liver disease in patients with MASLD, initiating from simple steatosis to progressive fibrosis and cirrhosis [40].